1
|
Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group.
|
Lancet
|
1998
|
6.17
|
2
|
Safety and tolerability of high doses of taspoglutide, a once-weekly human GLP-1 analogue, in diabetic patients treated with metformin: a randomized double-blind placebo-controlled study.
|
Diabet Med
|
2010
|
0.98
|
3
|
Taspoglutide, a once-weekly glucagon-like peptide 1 analogue, vs. insulin glargine titrated to target in patients with Type 2 diabetes: an open-label randomized trial.
|
Diabet Med
|
2013
|
0.88
|
4
|
Effect of orlistat-assisted weight loss in decreasing coronary heart disease risk in patients with syndrome X.
|
Am J Cardiol
|
2001
|
0.84
|
5
|
Efficacy and tolerability of taspoglutide versus pioglitazone in subjects with type 2 diabetes uncontrolled with sulphonylurea or sulphonylurea-metformin therapy: a randomized, double-blind study (T-emerge 6).
|
Diabetes Obes Metab
|
2012
|
0.81
|
6
|
Comparative evaluation of fecal fat excretion induced by orlistat and chitosan.
|
Obes Res
|
2001
|
0.78
|
7
|
A direct comparison of long- and short-acting GLP-1 receptor agonists (taspoglutide once weekly and exenatide twice daily) on postprandial metabolism after 24 weeks of treatment.
|
Diabetes Obes Metab
|
2013
|
0.78
|
8
|
Refinement of a transplantation project in the non-human primate by the use of a humane endpoint.
|
Lab Anim
|
2007
|
0.75
|
9
|
Refinement of a macaque transplantation model: application of a subcutaneous port as a means for long-term enteral drug administration and nutritional supplementation.
|
Lab Anim
|
2012
|
0.75
|
10
|
[Incidence and type of dyslipidemia in a diabetic population].
|
Clin Ter
|
1994
|
0.75
|
11
|
[Incidence and onset of arterial hypertension and diabetic retinopathy in a population of subjects with diabetes mellitus].
|
Clin Ter
|
1994
|
0.75
|
12
|
[Randomized placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients].
|
Ter Arkh
|
2000
|
0.75
|
13
|
[Autoimmune hypophysitis. Review of the literature and a case report].
|
Minerva Med
|
1993
|
0.75
|